Strides Pharma Science Q2 loss at Rs 149 crore
Total income, however, rose to Rs 1,035 crore in the second quarter as compared with Rs 920 crore in the year-ago period, Strides Pharma said in a regulatory filing.
Strides Pharma had reported a net profit of Rs 19 crore for the year-ago period, image- company website